Melanoma chondroitin sulfate proteoglycan enhances FAK and ERK activation by distinct mechanisms

Journal of Cell Biology

Volumn 165, Issue 6, 2004, Pages 881-891

  Yang, Jianbo ^a   Price, Matthew A ^a   Neudauer, Cheryl L ^a   Wilson, Christopher ^a   Ferrone, Soldano ^c   Xia, Hong ^a   Iida, Joji ^a   Simpson, Melanie A ^a,b   McCarthy, James B ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Cell spreading; ERK1 2; FAK; Integrin; Melanoma chondroitin sulfate proteoglycan

Indexed keywords

ALPHA4 INTEGRIN; CORE PROTEIN; FOCAL ADHESION KINASE; GROWTH FACTOR; INTEGRIN; MELANOMA CHONDROITIN SULFATE PROTEOGLYCAN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEOCHONDROITIN SULFATE; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; CANCER INVASION; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL SPREADING; CELL SURFACE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MELANOMA; METASTASIS; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; TUMOR CELL CULTURE; TUMOR CELL LINE; TUMOR GROWTH;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; ENZYME ACTIVATION; FOCAL ADHESION KINASE 1; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MELANOMA; MEMBRANE PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; PROTEIN-TYROSINE KINASES; PROTEOCHONDROITIN SULFATES; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 3042594595     PISSN: 00219525     EISSN: None     Source Type: Journal    
DOI: 10.1083/jcb.200403174     Document Type: Article

References (55)

1. Aplin, A.E., and R.L. Juliano. 1999. Integrin and cytoskeletal regulation of growth factor signaling to the MAP kinase pathway. J. Cell Sci. 112:695-706.
2. Barberis, L., K.K. Wary, G. Fiucci, F. Liu, E. Hirsch, M. Brancaccio, F. Altruda, G. Tarone, and F.G. Giancotti. 2000. Distinct roles of the adaptor protein Shc and focal adhesion kinase in integrin signaling to ERK. J. Biol. Chem. 275:36532-36540.
3. Bogenrieder, T., and M. Herlyn. 2002. Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma. Crit. Rev. Oncol. Hematol. 44:1-15.
4. Burg, M.A., K.A. Grako, and W.B. Stallcup. 1998. Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells. J. Cell. Physiol. 177:299-312.
5. Burridge, K., and M. Chrzanowska-Wodnicka. 1996. Focal adhesions, contractility, and signaling. Annu. Rev. Cell Dev. Biol. 12:463-518.
6. Chekenya, M., H.K. Rooprai, D. Davies, J.M. Levine, A.M. Butt, and G.J. Pilkington. 1999. The NG2 chondroitin sulfate proteoglycan: role in malignant progression of human brain tumours. Int. J. Dev. Neurosci. 17:421-435.
7. Conner, S.R., G. Scott, and A.E. Aplin. 2003. Adhesion-dependent activation of the ERKI/2 cascade is by-passed in melanoma cells. J. Biol. Chem. 278: 34548-34554.
8. Danen, E.H., and K.M. Yamada. 2001. Fibronectin, integrins, and growth control. J. Cell. Physiol. 189:1-13.
9. Danen, E.H., C. Marcinkiewicz, I.M. Cornelissen, A.A. van Kraats, J.A. Pachter, D.J. Ruiter, S. Niewiarowski, and G.N. van Muijen. 1998. The disintegrin eristostatin interferes with integrin α4β1 function and with experimental metastasis of human melanoma cells. Exp. Cell Res. 238:188-196.
10. Dedhar, S. 1999. Integrins and signal transduction. Curr. Opin. Hematol. 6:37-43.
11. Eisenmann, K.M., J.B. McCarthy, M.A. Simpson, P.J. Keely, J.L. Guan, K. Tachibana, L. Lim, E. Manser, L.T. Furcht, and J. Iida. 1999. Melanoma chondroitin sulphate proteoglycan regulates cell spreading through Cdc42, Ack-1 and p130cas. Nat. Cell Biol. 1:507-513.
12. Ferrone, S., M. Temponi, D. Gatgiulo, G.A. Scassellati, R. Cavaliere, and P.G. Natali. 1988. Selection and utilization of monoclonal antibody defined melanoma associated antigens for immunoscintigraphy in patients with melanoma. In Radiolabeled Monoclonal Antibodies for Imaging and Therapy. Vol. 152. S.C. Srivastava, editor. Plenum Publishing Corp., New York/London. 55-73.
13. Garrigues, H.J., M.W. Latk, S. Lara, I. Hellstrom, K.E. Hellstrom, and T.N. Wight. 1986. The melanoma proteoglycan: restricted expression on microspikes, a specific microdomain of the cell surface. J. Cell Biol. 103:1699-1710.
14. Geller, A.C., and G.D. Annas. 2003. Epidemiology of melanoma and nonmelanoma skin cancer. Semin. Oncol. Nurs. 19:2-11.
15. Giacomini, P., A.K. Ng, R.R. Kantor, P.G. Natali, and S. Ferrone. 1983. Double determinant immunoassay to measure a human high-molecular-weight melanoma-associated antigen. Cancer Res. 43:3586-3590.
16. Giancotti, F.G., and E. Ruoslahti. 1999. Integrin signaling. Science. 285:1028-1032.
17. Goretzki, L., M.A. Burg, K.A. Grako, and W.B. Stallcup. 1999. High-affinity binding of basic fibroblast growth factor and platelet-derived growth factor-AA to the core protein of the NG2 proteoglycan. J. Biol. Chem. 274:16831-16837.
18. Guan, J.L. 1997. Role of focal adhesion kinase in integrin signaling. Int. J. Biochem. Cell Biol. 29:1085-1096.
19. Hauck, C.R., D.A. Hsia, and D.D. Schlaepfer. 2002. The focal adhesion kinase - a regulator of cell migration and invasion. IUBMB Life. 53:115-119.
20. Hecker, T.P., and C.L. Gladson. 2003. Focal adhesion kinase in cancer. Front. Biosci. 8:s705-s714.
21. Hilden, J.M., F.O. Smith, J.L. Frestedt, R. McGlennen, W.B. Howells, P.H. Sorensen, D.C. Arthur, W.G. Woods, J. Buckley, I.D. Bernstein, and J.H. Kersey. 1997. MLL gene rearrangement, cytogenetic 1 1q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia. Blood. 89:3801-3805.
22. Hood, J.D., and D.A. Cheresh. 2002. Role of integrins in cell invasion and migration. Nat. Rev. Cancer. 2:91-100.
23. Houghton, A.N., and D. Polsky. 2002. Focus on melanoma. Cancer Cell. 2:275-278.
24. Howe, A.K., A.E. Aplin, and R.L. Juliano. 2002. Anchorage-dependent ERK signaling - mechanisms and consequences. Curr. Opin. Genet. Dev. 12:30-35.
25. Iida, J., A.P. Skubitz, L.T. Furcht, E.A. Wayner, and J.B. McCarthy. 1992. Coordinate role for cell surface chondroitin sulfate proteoglycan and α4β1 integrin in mediating melanoma cell adhesion to fibronectin, J. Cell Biol. 118: 431-444.
26. Iida, J., A.M. Meijne, R.C. Spiro, E. Roos, L.T. Furcht, and J.B. McCarthy. 1995. Spreading and focal contact formation of human melanoma cells in response to the stimulation of both melanoma-associated proteoglycan (NG2) and α4β1 integrin. Cancer Res. 55:2177-2185.
27. Iida, J., A.M. Meijne, J.R. Knutson, L.T. Furcht, and J.B. McCarthy. 1996. Cell surface chondroitin sulfate proteoglycans in tumor cell adhesion, motility and invasion. Semin. Cancer Biol. 7:155-162.
28. Iida, J., D. Pei, T. Kang, M.A. Simpson, M. Herlyn, L.T. Furcht, and J.B. McCarthy. 2001. Melanoma chondroitin sulfate proteoglycan regulates matrix metalloproteinase-dependent human melanoma invasion into type I collagen. J. Biol. Chem. 276:18786-18794.
29. Johnson, J.P. 1999. Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev. 18:345-357.
30. Juliano, R.L. 2002. Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. Annu. Rev. Pharmacol. Toxicol. 42:283-323.
31. Kageshita, T., N. Kuriya, T. Ono, T. Horikoshi, M. Takahashi, G.Y. Wong, and S. Ferrone. 1993. Association of high molecular weight melanoma-associated antigen expression in primary acral lentiginous melanoma lesions with poor prognosis. Cancer Res. 53:2830-2833.
32. Kahana, O., M. Micksche, I.P. Witz, and I. Yron. 2002. The focal adhesion kinase (P125FAK) is constitutively active in human malignant melanoma. Oncogene. 21:3969-3977.
33. Li, G., K. Satyamoorthy, and M. Herlyn. 2002. Dynamics of cell interactions and communications during melanoma development. Crit. Rev. Oral Biol. Med. 13:62-70.
34. Lin, T.H., A.E. Aplin, Y. Shen, Q. Chen, M. Schaller, L. Romer, I. Aukhil, and R.L. Juliano. 1997. Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J. Cell Biol. 136:1385-1395.
35. Majumdar, M., K. Vuoti, and W.B. Stallcup. 2003. Engagement of the NG2 proteoglycan triggers cell spreading via tac and p130cas. Cell. Signal. 15:79-84.
36. Mansout, S.J., W.T. Matten, A.S. Hetmann, J.M. Candia, S. Rong, K. Fukasawa, G.F. Van de Woude, and N.G. Ahn. 1994. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science. 265:966-970.
37. McCarthy, J.B., M.K. Chelberg, D.J. Mickelson, and L.T. Furcht. 1988. Localization and chemical synthesis of fibronectin peptides with melanoma adhesion and heparin binding activities. Biochemistry. 27:1380-1388.
38. Morgan, A.C., Jr., D.R. Galloway, and R.A. Reisfeld. 1981. Production and characterization of monoclonal antibody to a melanoma specific glycoprotein. Hybridoma. 1:27-36.
39. Mould, A.P., J.A. Askari, S.E. Craig, A.N. Gartatt, J. Clements, and M.J. Humphries. 1994. Integrin α4β1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-I (VCAM-1) and the alternatively spliced IIICS tegion of fibronectin. J. Biol. Chem. 269:27224-27230.
40. Neudauer, C.L., and J.B. McCarthy. 2003. Insulin-like growth factor I-stimulated melanoma cell migration requires phosphoinositide 3-kinase but not extracellular-regulated kinase activation. Exp. Cell Res. 286:128-137.
41. Nishiyama, A. 2001. NG2 cells in the brain: a novel glial cell population. Hum. Cell. 14:77-82.
42. Nishiyama, A., K.J. Dahlin, J.T. Prince, S.R. Johnstone, and W.B. Stallcup. 1991. The primary structure of NG2, a novel membrane-spanning proteoglycan. J. Cell Biol. 114:359-371.
43. Pluschke, G., M. Vanek, A. Evans, T. Dittmar, P. Schmid, P. Itin, E.J. Filardo, and R.A. Reisfeld. 1996. Molecular cloning of a human melanoma-associated chondroitin sulfate proteoglycan. Proc. Natl. Acad. Sci. USA. 93:9710-9715.
44. Satyamoorthy, K., E. DeJesus, A.J. Linnenbach, B. Kraj, D.L. Kornreich, S. Rendle, D.E. Elder, and M. Herlyn. 1997. Melanoma cell lines from different stages of progression and their biological and molecular analyses. Melanoma Res. 7:S35-S42.
45. Satyamoorthy, K., G. Li, M.R. Gerrero, M.S. Brose, P. Volpe, B.L. Weber, P. Van Belle, D.E. Elder, and M. Herlyn. 2003. Constitutive mitogen-activated protein kinase activation in melanoma is mediated by both BRAF mutations and autocrine growth factor stimulation. Cancer Res. 63:756-759.
46. Schlaepfer, D.D., and T. Hunter. 1996. Signal transduction from the extracellular matrix-a role for the focal adhesion protein-tyrosine kinase FAK. Cell Struct. Funct. 21:445-450.
47. Schlaepfer, D.D., and T. Hunter. 1997. Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen- activated protein kinase through interactions with and activation of c-Src. J. Biol. Chem. 272: 13189-13195.
48. Schlaepfer, D.D., C.R. Hauck, and D.J. Sieg. 1999. Signaling through focal adhesion kinase. Prog. Biophys. Mol. Biol. 71:435-478.
49. Sharma, A., J.A. Askari, M.J. Humphries, E.Y. Jones, and D.I. Stuart. 1999. Crystal structure of a heparin- and integrin-binding segment of human fibronectin. EMBO J. 18:1468-1479.
50. Sieg, D.J., C.R. Hauck, D. Ilic, C.K. Klingbeil, E. Schaefer, C.H. Damsky, and D.D. Schlaepfet. 2000. FAK integrates growth-factor and integrin signals to promote cell migration. Nat. Cell Biol. 2:249-256.
51. Smalley, K.S. 2003. A pivotal role for ERK in the oncogenic behaviour of malignant melanoma? Int. J. Cancer. 104:527-532.
52. Stallcup, W.B. 2002. The NG2 proteoglycan: past insights and future prospects. J. Neurocytol. 31:423-435.
53. Staub, E., B. Hinzmann, and A. Rosenthal. 2002. A novel repeat in the melanoma-associated chondroitin sulfate proteoglycan defines a new protein family. FEBS Lett. 527:114-118.
54. Wakatsuki, T., R.B. Wysolmerski, and E.L. Elson. 2003. Mechanics of cell spreading: role of myosin II. J. Cell Sci. 116:1617-1625.
55. Wayner, E.A., A. Garcia-Pardo, M.J. Humphries, J.A. McDonald, and W.G. Carter. 1989. Identification and characterization of the T lymphocyte adhesion receptor for an alternative cell attachment domain (CS-1) in plasma fibronectin. J. Cell Biol. 109:1321-1330.